AVCNF (Avicanna) Margin of Safety % (DCF Earnings Based): N/A (As of Jun. 28, 2026)


AVCNF Avicanna Inc AVCNF
53 GF Score
Price $0.09
GF Value $0.20
Valuation Possible Value Trap
! 2 Warning Signs
View Full Analysis

What is Avicanna Margin of Safety % (DCF Earnings Based)?

Margin of Safety % (DCF Earnings Based) = (Intrinsic Value: DCF (Earnings Based) - Current Price) / Intrinsic Value: DCF (Earnings Based).

Note: Discounted Earnings model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

Avicanna's Predictability Rank is Not Rated. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF Earnings Based) is not calculated.

AVCNF vs ZTS: Margin of Safety % (DCF Earnings Based) Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Avicanna's Margin of Safety % (DCF Earnings Based), along with its competitors' market caps and Margin of Safety % (DCF Earnings Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Avicanna Margin of Safety % (DCF Earnings Based) vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Avicanna's Margin of Safety % (DCF Earnings Based) distribution charts can be found below:

* The bar in red indicates where Avicanna's Margin of Safety % (DCF Earnings Based) falls into.


AVCNF
53GF Score
Avicanna Inc AVCNF
Margin of Safety % (DCF Earnings Based) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Avicanna (AVCNF) Overvalued in 2026?

Based on GuruFocus' analysis, Avicanna stock appears to be undervalued. The current stock price of $0.09 is trading 57.5% below its estimated GF Value™ of $0.20. GuruFocus considers Avicanna to be Possible Value Trap.

Key valuation signals for AVCNF:

  • Margin of Safety % (DCF Earnings Based): N/A
  • GF Value™: $0.20 vs. price of $0.09 (57.5% below fair value)
  • GF Score™: 53/100 with 2 warning signs

No single metric tells the full story. See the AVCNF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Avicanna Business Description

Other Exchanges 0NN:GermanyAVCN:Canada
Address 480 University Avenue, Suite 1502, Toronto, BC, CAN, M5G 1V2
Avicanna Inc is a commercial-stage international biopharmaceutical company focused on the development, advancement, and commercialization of evidence-based cannabinoid-based products and formulations for the medical and pharmaceutical market segments. It has three operating segments: Canada, International, and Corporate. It generates the majority of its revenue from Canada.
53GF Score

Get the complete analysis for AVCNF

Margin of Safety % (DCF Earnings Based) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.09
Price
$0.20
GF Value